AcuCort AB signs a comprehensive distrubution agreement

Having been in the making for a long time, AcuCort AB last week finally announced the signing of a distribution agreement with Glenmark Pharmaceuticals for AcuCort's product, Zeqmelit®for treating acute allergic reactions.

Being among the 100 biggest biopharmaceutical companies globally, Glenmark Pharmaceuticals is a great and very capable partner for AcuCort AB.
The agreement covers 6 countries in Europe: Germany, the Netherlands, the Czech Republic, Austria, Slovakia, and Ukraine and adds coverage of 160 million people when rolled out in all 6 countries. 

See the official press release here